Report cover image

Europe Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Mar 21, 2024
Length 143 Pages
SKU # KBV18686807

Description

Europe Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030


The Europe Microbiome Diagnostics Market would witness market growth of 17.0% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24,425.8 Thousands by 2030. The UK market is showcasing a CAGR of 16% during (2023 - 2030). Additionally, The France market would register a CAGR of 17.9% during (2023 - 2030).

It is crucial in understanding the link between the gut microbiome and metabolic disorders such as obesity, type 2 diabetes, and metabolic syndrome. Research has shown that gut microbiota composition and function alterations can influence host metabolism, energy balance, and insulin sensitivity. It can identify microbial biomarkers associated with metabolic dysfunction, providing insights into disease mechanisms and potential therapeutic targets.

Likewise, the microbiome plays a central role in modulating immune function and responses. It studies how the gut microbiome interacts with the immune system and influences immune-mediated diseases such as allergies, autoimmune disorders, and inflammatory conditions. By profiling the microbiome-immune axis, it can identify microbial signatures associated with immune dysregulation and inflammatory diseases, informing therapeutic interventions and immune-modulating strategies. Also, the skin microbiome has emerged as a key player in maintaining skin health and integrity. It is utilized to study the composition and diversity of microbial communities on the skin and their role in dermatological conditions such as acne, eczema, psoriasis, and wound healing. Understanding the skin microbiome’s dynamics and its interaction with the host can inform personalized skincare interventions and therapeutic approaches for various dermatological ailments.

In addition, the high prevalence of respiratory diseases in Europe drives demand for microbiome diagnostics in research and clinical settings. According to Eurostat, respiratory illnesses accounted for 347 867 deaths in the EU in 2020 or 6.7% of all fatalities among citizens. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively. As research continues to unravel the complex interplay between the respiratory microbiome and respiratory health, it will play an increasingly critical role in shaping the future of respiratory medicine in Europe and beyond. Thus, the high prevalence of respiratory diseases and the expansion of the pharmaceutical industry in the region is propelling the market’s growth.

Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Illumina, Inc.
  • Becton, Dickinson and Company
  • Genetic Analysis AS
  • Microba Life Sciences Limited
  • BioMe Oxford Ltd
  • Viome Life Sciences, Inc.
  • GoodGut S.L.U. (HIPRA, S.A.)
  • Sun Genomics
  • Origin Sciences Limited
  • Decode Age
Europe Microbiome Diagnostics Market Report Segmentation

By Application
  • Disease Diagnostics
  • Gastrointestinal Disorders
  • Metabolic Diseases
  • Others
  • Research Application
By Product
  • Reagents & Kits
  • Instruments
By Sample
  • Fecal
  • Saliva
  • Skin
  • Others
By Technology
  • 16S rRNA Sequencing
  • Shot Gun Metagenomics
  • Metatranscriptomics
  • Others
By End User
  • Hospitals
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

143 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microbiome Diagnostics Market, by Application
1.4.2 Europe Microbiome Diagnostics Market, by Product
1.4.3 Europe Microbiome Diagnostics Market, by Sample
1.4.4 Europe Microbiome Diagnostics Market, by Technology
1.4.5 Europe Microbiome Diagnostics Market, by End User
1.4.6 Europe Microbiome Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. Europe Microbiome Diagnostics Market by Application
5.1 Europe Disease Diagnostics Market by Country
5.2 Europe Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 Europe Gastrointestinal Disorders Market by Country
5.2.2 Europe Metabolic Diseases Market by Country
5.2.3 Europe Others Market by Country
5.3 Europe Research Application Market by Country
Chapter 6. Europe Microbiome Diagnostics Market by Product
6.1 Europe Reagents & Kits Market by Country
6.2 Europe Instruments Market by Country
Chapter 7. Europe Microbiome Diagnostics Market by Sample
7.1 Europe Fecal Market by Country
7.2 Europe Saliva Market by Country
7.3 Europe Skin Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Microbiome Diagnostics Market by Technology
8.1 Europe 16S rRNA Sequencing Market by Country
8.2 Europe Shot Gun Metagenomics Market by Country
8.3 Europe Metatranscriptomics Market by Country
8.4 Europe Others Market by Country
Chapter 9. Europe Microbiome Diagnostics Market by End User
9.1 Europe Hospitals Market by Country
9.2 Europe Academic & Research Institutes Market by Country
9.3 Europe Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10. Europe Microbiome Diagnostics Market by Country
10.1 Germany Microbiome Diagnostics Market
10.1.1 Germany Microbiome Diagnostics Market by Application
10.1.1.1 Germany Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 Germany Microbiome Diagnostics Market by Product
10.1.3 Germany Microbiome Diagnostics Market by Sample
10.1.4 Germany Microbiome Diagnostics Market by Technology
10.1.5 Germany Microbiome Diagnostics Market by End User
10.2 UK Microbiome Diagnostics Market
10.2.1 UK Microbiome Diagnostics Market by Application
10.2.1.1 UK Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 UK Microbiome Diagnostics Market by Product
10.2.3 UK Microbiome Diagnostics Market by Sample
10.2.4 UK Microbiome Diagnostics Market by Technology
10.2.5 UK Microbiome Diagnostics Market by End User
10.3 France Microbiome Diagnostics Market
10.3.1 France Microbiome Diagnostics Market by Application
10.3.1.1 France Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 France Microbiome Diagnostics Market by Product
10.3.3 France Microbiome Diagnostics Market by Sample
10.3.4 France Microbiome Diagnostics Market by Technology
10.3.5 France Microbiome Diagnostics Market by End User
10.4 Russia Microbiome Diagnostics Market
10.4.1 Russia Microbiome Diagnostics Market by Application
10.4.1.1 Russia Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Russia Microbiome Diagnostics Market by Product
10.4.3 Russia Microbiome Diagnostics Market by Sample
10.4.4 Russia Microbiome Diagnostics Market by Technology
10.4.5 Russia Microbiome Diagnostics Market by End User
10.5 Spain Microbiome Diagnostics Market
10.5.1 Spain Microbiome Diagnostics Market by Application
10.5.1.1 Spain Microbiome Diagnostics Market by Disease Diagnostics Type
10.5.2 Spain Microbiome Diagnostics Market by Product
10.5.3 Spain Microbiome Diagnostics Market by Sample
10.5.4 Spain Microbiome Diagnostics Market by Technology
10.5.5 Spain Microbiome Diagnostics Market by End User
10.6 Italy Microbiome Diagnostics Market
10.6.1 Italy Microbiome Diagnostics Market by Application
10.6.1.1 Italy Microbiome Diagnostics Market by Disease Diagnostics Type
10.6.2 Italy Microbiome Diagnostics Market by Product
10.6.3 Italy Microbiome Diagnostics Market by Sample
10.6.4 Italy Microbiome Diagnostics Market by Technology
10.6.5 Italy Microbiome Diagnostics Market by End User
10.7 Rest of Europe Microbiome Diagnostics Market
10.7.1 Rest of Europe Microbiome Diagnostics Market by Application
10.7.1.1 Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type
10.7.2 Rest of Europe Microbiome Diagnostics Market by Product
10.7.3 Rest of Europe Microbiome Diagnostics Market by Sample
10.7.4 Rest of Europe Microbiome Diagnostics Market by Technology
10.7.5 Rest of Europe Microbiome Diagnostics Market by End User
Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us